McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 



